Tirzepatide causes nausea in 3045% of patients during dose titration, peaking 2472 hours post-injection and typically resolving within 48 weeks
In individuals with pre-existing gastrointestinal conditions such as inflammatory bowel disease, coeliac disease, or irritable bowel syndrome, introducing any new supplement may temporarily affect bowel habits as the digestive system adapts
Newmark, H
CPT1A activity can be regulated via the AMPK-ACC-CPT1A axis (Figure 6) (Yao et al., 2020)
While the exact cause of SLE is unknown, it is believed to involve a combination of genetic, hormonal, and environmental factors, with individuals assigned female at birth and those of African American, American Indian, and Asian descent being at higher risk